Skip to content

Live birth rate after preimplantation genetic testing for aneuploidy versus conventional in vitro fertilization among couples with recurrent pregnancy loss: A multicenter randomized controlled clinical trial

Live birth rate after preimplantation genetic testing for aneuploidy versus conventional in vitro fertilization among couples with recurrent pregnancy loss: A multicenter randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107243
Enrollment
Unknown
Registered
2025-08-06
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent pregnancy loss

Interventions

IVF/ICSI group:IVF/ICSI
PGT-A group:PGT-A

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1.women with a history of RPL, RPL refers to a history of >= 2 pregnancy losses before 24 weeks of gestation, among which at least 1 was clinical pregnancy loss; 2. Women under the age of 40 years at the time of informed consent; 3. Women who intend to undergo ART; 4. Women with at least 1 good-quality blastocysts on day 5 or day 6 of embryo culture; 5. Be capable of giving informed consent.

Exclusion criteria

Exclusion criteria: 1. Women with a uterine cavity abnormality, such as a uterine congenital malformation (uterus unicornate, bicornate, or duplex); untreated uterine septum, submucous myoma, multiple endometrial polyp(s); or with untreated hydrosalpinx; 2. Women who are indicated and planned to undergo PGT-M or PGT-SR; 3. Women who use donated oocytes or sperm to achieve pregnancy; 4. Women with medical contraindications to assisted reproductive technology and/or pregnancy.

Design outcomes

Primary

MeasureTime frame
Live birth rate after initial transfer;

Secondary

MeasureTime frame
Neonatal complications, birth weight and birth defects;Ongoing pregnancy rate;Biochemical pregnancy rate;Good birth outcome;Pregnancy loss rate;Complications during pregnancy and childbirth;clinical pregnancy outcome;

Countries

China

Contacts

Public ContactYun Sun

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

syun163@163.com+86 21 2028 4500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026